Citation: D. Dornan et Tr. Hupp, Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300, EMBO REP, 2(2), 2001, pp. 139-144
Authors:
Blaydes, JP
Luciani, MG
Pospisilova, S
Ball, HML
Vojtesek, B
Hupp, TR
Citation: Jp. Blaydes et al., Stoichiometric phosphorylation of human p53 at Ser(315) stimulates p53-dependent transcription, J BIOL CHEM, 276(7), 2001, pp. 4699-4708
Authors:
Yagui-Beltran, A
Craig, AL
Lawrie, L
Thompson, D
Pospisilova, S
Johnston, D
Kernohan, N
Hopwood, D
Dillon, JF
Hupp, TR
Citation: A. Yagui-beltran et al., The human oesophageal squamous epithelium exhibits a novel type of heat shock protein response, EUR J BIOCH, 268(20), 2001, pp. 5343-5355
Authors:
Ball, HML
Hupp, TR
Ziyaie, D
Purdie, CA
Kernohan, NM
Thompson, AM
Citation: Hml. Ball et al., Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring, BR J CANC, 85(8), 2001, pp. 1102-1105
Authors:
Blaydes, JP
Craig, AL
Wallace, M
Ball, HML
Traynor, NJ
Gibbs, NK
Hupp, TR
Citation: Jp. Blaydes et al., Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways, ONCOGENE, 19(34), 2000, pp. 3829-3839
Authors:
Luciani, MG
Hutchins, JRA
Zheleva, D
Hupp, TR
Citation: Mg. Luciani et al., The C-terminal regulatory domain of p53 contains a functional docking sitefor cyclin A, J MOL BIOL, 300(3), 2000, pp. 503-518
Authors:
Blaydes, JP
Vojtesek, B
Bloomberg, GB
Hupp, TR
Citation: Jp. Blaydes et al., The development and use of phospho-specific antibodies to study protein phosphorylation, METH MOL B, 99, 2000, pp. 177-189
Authors:
Craig, AL
Blaydes, JP
Burch, LR
Thompson, AM
Hupp, TR
Citation: Al. Craig et al., Dephosphorylation of p53 at Ser20 after cellular exposure to low levels ofnon-ionizing radiation, ONCOGENE, 18(46), 1999, pp. 6305-6312
Authors:
Craig, AL
Burch, L
Vojtesek, B
Mikutowska, J
Thompson, A
Hupp, TR
Citation: Al. Craig et al., Novel phosphorylation sites of human tumour suppressor protein p53 at Ser(20) and Thr(18) that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers, BIOCHEM J, 342, 1999, pp. 133-141
Citation: Pa. Cohen et al., Biochemical characterization of different conformational states of the Sf9cell-purified p53His175 mutant protein, FEBS LETTER, 463(1-2), 1999, pp. 179-184